Cargando…
Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle?
Autores principales: | Koufakis, Theocharis, Vas, Prashanth, Maltese, Giuseppe, Kotsa, Kalliopi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516036/ https://www.ncbi.nlm.nih.gov/pubmed/35245937 http://dx.doi.org/10.1210/clinem/dgac116 |
Ejemplares similares
-
Potential Role of Ultrafast-acting Insulin Analogues in the Treatment of Diabetic Ketoacidosis
por: Koufakis, Theocharis, et al.
Publicado: (2022) -
From Skepticism to Hope: The Evolving Concept of the Initiation and Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients
por: Koufakis, Theocharis, et al.
Publicado: (2022) -
The importance of sleep quality, quantity, and chronotype in the management of diabetes: Is it time to wake up?
por: Koufakis, Theocharis, et al.
Publicado: (2022) -
Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases
por: Koufakis, Theocharis, et al.
Publicado: (2021) -
Looking deeper into the findings of DARE-19: Failure or an open door to future success?
por: Koufakis, Theocharis, et al.
Publicado: (2021)